Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 34
Filter
Add more filters










Publication year range
1.
Clin Exp Immunol ; 152(3): 508-16, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18462208

ABSTRACT

The neutrophil serine protease proteinase 3 (PR3) is a main autoantigen in anti-neutrophil cytoplasmic antibody-associated vasculitis. PR3 surface presentation on neutrophilic granulocytes, the main effector cells, is pathogenically important. PR3 is presented by the NB1 (CD177) glycoprotein, but how the presentation develops during neutrophil differentiation is not known. An N-terminally unprocessed PR3 (proPR3) is produced early during neutrophil development and promotes myeloid cell differentiation. We therefore investigated if PR3 presentation depended on NB1 during neutrophil differentiation and if PR3 and proPR3 could both be presented by NB1. In contrast to mature neutrophils, differentiating neutrophils showed an early NB1-independent PR3 surface display that was recognized by only two of four monoclonal anti-PR3 antibodies and occurred in parallel with proPR3, but not PR3 secretion, suggesting that the NB1-independent surface PR3 was proPR3. PR3 gene expression preceeded NB1. When the NB1 receptor was detected on the surface, a mode of PR3 surface display similar to mature neutrophils developed together with the degranulation system. Ectopic expression studies showed that NB1 was a sufficient receptor for PR3 but not proPR3. ProPR3 display on the plasma membrane may influence the bone marrow microenvironment. NB1-mediated PR3 presentation depended on PR3 N-terminal processing implicating the PR3-N-terminus as NB1-binding site.


Subject(s)
Antibodies, Antineutrophil Cytoplasmic/immunology , Antigen Presentation/immunology , Isoantigens/immunology , Membrane Glycoproteins/immunology , Myeloblastin/immunology , Neutrophils/immunology , Receptors, Cell Surface/immunology , Adult , Cell Differentiation , Cells, Cultured , GPI-Linked Proteins , Gene Expression Regulation/immunology , Humans , Infant, Newborn , Isoantigens/genetics , Membrane Glycoproteins/genetics , Myeloblastin/genetics , Myeloblastin/metabolism , Neutrophils/cytology , RNA, Messenger/genetics , Receptors, Cell Surface/genetics , Reverse Transcriptase Polymerase Chain Reaction/methods , Translocation, Genetic
2.
Horm Metab Res ; 38(1): 28-33, 2006 Jan.
Article in English | MEDLINE | ID: mdl-16477537

ABSTRACT

Adipocytes produce the endothelial-cell specific molecule-1 (ESM-1), which inhibits leukocyte adhesion and migration through the endothelium. This study investigates ESM-1 expression and regulation in human adipose tissue. Subcutaneous abdominal adipose tissue was obtained from seventy postmenopausal women. Fourteen women subsequently underwent non-pharmacological weight reduction. In vitro experiments were performed on adipocytes isolated from human mammary adipose tissue. We determined gene expression by TaqMan RT-PCR and measured ESM-1 levels in serum and cell culture medium by ELISA. Mature adipocytes produced ESM-1. ESM-1 gene expression was higher in adipocytes than in preadipocytes. Cortisol inhibited ESM-1 gene expression in preadipocytes. Insulin and cortisol inhibited adipocyte ESM-1 production in adipocytes. This inhibitory effect of insulin was attenuated by insulin resistance, as ESM-1 gene expression in subcutaneous adipose tissue was increased in obese, hyperinsulinemic women. In contrast, ESM-1 serum levels were reduced in obese women and inversely correlated to C-reactive protein levels. Five percent weight loss did not markedly change gene expression. Circulating ESM-1 levels increased significantly, albeit modestly. ESM-1 is actively produced by adipocytes. However, since ESM-1 adipocyte gene expression and circulating plasma levels are not correlated, other sources of ESM-1 may be more important. Circulating ESM-1 levels are reduced in the overweight and obese, consistent with the notion that ESM-1 may play some role in obesity-associated vascular disease.


Subject(s)
Adipocytes/metabolism , Gene Expression Regulation , Neoplasm Proteins/biosynthesis , Obesity/metabolism , Proteoglycans/biosynthesis , Subcutaneous Fat, Abdominal/metabolism , Adipocytes/pathology , Adult , Aged , Cells, Cultured , Female , Humans , Hyperinsulinism/etiology , Hyperinsulinism/metabolism , Hyperinsulinism/pathology , Mammary Glands, Human/metabolism , Mammary Glands, Human/pathology , Middle Aged , Obesity/complications , Obesity/pathology , Obesity/surgery , Subcutaneous Fat, Abdominal/pathology , Vascular Diseases/etiology , Vascular Diseases/metabolism , Vascular Diseases/pathology , Weight Loss
3.
Phys Med Biol ; 50(2): 215-29, 2005 Jan 21.
Article in English | MEDLINE | ID: mdl-15742940

ABSTRACT

Voltage-sensitive dyes are an important tool in visualizing electrical activity in cardiac tissue. Until today, they have mainly been applied in cardiac electrophysiology to subsurface imaging. In the present study, we assess different imaging methods used in optical tomography with respect to their effectiveness in visualizing 3D cardiac activity. To achieve this goal, we simulate optical signals produced by excitation fronts initiated at different depths inside the myocardial wall and compare their properties for various imaging modes. Specifically, we consider scanning and broad-field illumination, including trans- and epi-illumination. We focus on the lateral optical resolution and signal intensity, as a function of the source depth. Optical diffusion theory is applied to derive a computationally efficient approximation of the point-spread function and to predict voltage-sensitive signals. Computations were performed both for fluorescent and absorptive voltage-sensitive dyes. Among all the above-mentioned methods, fluorescent coaxial scanning yields the best resolution (<2.5 mm) and gives the most information about the intramural cardiac activity.


Subject(s)
Body Surface Potential Mapping/methods , Heart Conduction System/physiology , Image Interpretation, Computer-Assisted/methods , Imaging, Three-Dimensional/methods , Microscopy, Fluorescence/methods , Models, Cardiovascular , Tomography, Optical/methods , Action Potentials/physiology , Animals , Computer Simulation , Fluorescent Dyes , Humans , Membrane Potentials/physiology , Models, Neurological
4.
Phys Rev E Stat Nonlin Soft Matter Phys ; 70(6 Pt 1): 061913, 2004 Dec.
Article in English | MEDLINE | ID: mdl-15697408

ABSTRACT

The cardiac muscle is well known to conduct electric impulses anisotropically, showing a larger conduction velocity along than across fibers. Fiber orientation is not uniform within the cardiac wall, but rotates by as much as 180 degrees throughout the wall thickness. Numerical simulations and experiments have indicated that this rotational anisotropy considerably affects the spread of excitation in cardiac tissue: the wave front shows a complex intramural shape with trailing cusps. The cusps can travel across layers and reach the epicardial and endocardial surfaces where they cause apparent accelerations of propagation. In the present study we provide an analytical description of the asymptotic wave front, as well as of cusp waves. We investigate the motion of cusp waves, based on the assumption that they occur at the intersection of asymptotic solutions, and we show that our theoretical analysis is in close agreement with numerical simulations. The asymptotic solutions are found to be determined purely by the fiber organization within the cardiac wall, independent of the excitable properties of cardiac tissue.


Subject(s)
Action Potentials/physiology , Heart Conduction System/physiology , Models, Cardiovascular , Models, Neurological , Muscle Cells/physiology , Synaptic Transmission/physiology , Ventricular Function , Animals , Anisotropy , Computer Simulation , Humans
5.
Horm Metab Res ; 35(4): 217-21, 2003 Apr.
Article in English | MEDLINE | ID: mdl-12778364

ABSTRACT

Expression of the endothelial cell-specific molecule (ESM)-1 was originally identified in lung and kidney endothelial cells, where its expression is regulated by cytokines. In vitro, ESM-1 interferes with the molecular mechanisms of immune cell migration by binding to adhesion molecules. In this study, we have explored the expression of ESM-1 in isolated human adipocytes and in rat adipose tissue depots. Human primary adipocytes were cultivated after collagenase digestion and used for in vitro incubation studies. Adipocytes were also isolated from different fat depots of Sprague-Dawley rats. Gene expression was quantified by TaqMan RT-PCR using specific human and rat ESM-1 primers. The cellular localisation of ESM-1 was determined by confocal microscopy using a specific antibody. ESM-1 expression in human adipocytes was stimulated by phorbol ester, an activator of protein kinase C, and by retinoic acid, an activator of nuclear receptors. The maximum increase in gene expression was 3.2-fold after 72 h treatment with phorbol ester and 4.6-fold after 72 h treatment with retinoic acid. The highest expression was found in subcutaneous rat adipose tissue - two-fold compared to epididymal and six-fold compared to intrascapular brown adipose tissue. As obesity is related to systemic inflammation (examplified by increased circulating levels of C-reactive protein and interleukin-6), the formation of ESM-1 in adipocytes and its activation by protein kinase C may play a role in the regulation of inflammatory processes.


Subject(s)
Adipocytes/chemistry , Gene Expression/drug effects , Neoplasm Proteins , Proteoglycans/physiology , Animals , Cells, Cultured , DNA Primers , Humans , In Vitro Techniques , Microscopy, Fluorescence , Phorbol Esters/pharmacology , Proteoglycans/genetics , Rats , Rats, Sprague-Dawley , Reverse Transcriptase Polymerase Chain Reaction , Tretinoin/pharmacology
6.
Circ Res ; 89(11): 1051-7, 2001 Nov 23.
Article in English | MEDLINE | ID: mdl-11717163

ABSTRACT

Intracellular Ca(2+) levels control both contraction and relaxation in vascular smooth muscle cells (VSMCs). Ca(2+)-dependent relaxation is mediated by discretely localized Ca(2+) release events through ryanodine receptor (RyR) channels in the sarcoplasmic reticulum (SR). These local increases in Ca(2+) concentration, termed sparks, stimulate nearby Ca(2+)-activated K(+) (BK) channels causing BK currents (spontaneous transient outward currents or STOCs). STOCs are hyperpolarizing currents that oppose vasoconstriction. Several RyR isoforms are coexpressed in VSMCs; however, their role in Ca(2+) spark generation is unknown. To provide molecular information on RyR cluster function and assembly, we examined Ca(2+) sparks and STOCs in RyR3-deficient freshly isolated myocytes of resistance-sized cerebral arteries from knockout mice and compared them to Ca(2+) sparks in cells from wild-type mice. We used RT-PCR to identify RyR1, RyR2, and RyR3 mRNA in cerebral arteries. Ca(2+) sparks in RyR3-deficient cells were similar in peak amplitude (measured as F/F(0)), width at half-maximal amplitude, and duration compared with wild-type cell Ca(2+) sparks. However, the frequency of STOCs (between -60 mV and -20 mV) was significantly higher in RyR3-deficient cells than in wild-type cells. Ca(2+) sparks and STOCs in both RyR3-deficient and wild-type cells were inhibited by ryanodine (10 micromol/L), external Ca(2+) removal, and depletion of SR Ca(2+) stores by caffeine (1 mmol/L). Isolated, pressurized cerebral arteries of RyR3-deficient mice developed reduced myogenic tone. Our results suggest that RyR3 is part of the SR Ca(2+) spark release unit and plays a specific molecular role in the regulation of STOCs frequency in mouse cerebral artery VSMCs after decreased arterial tone.


Subject(s)
Arteries/cytology , Calcium Signaling , Calcium/metabolism , Muscle, Smooth, Vascular/physiology , Potassium Channels, Calcium-Activated/physiology , Ryanodine Receptor Calcium Release Channel/physiology , Animals , Cells, Cultured , Cerebral Arteries/cytology , Cerebral Arteries/physiology , Electric Conductivity , Ion Transport , Mice , Mice, Knockout , Models, Cardiovascular , Protein Isoforms/biosynthesis , Protein Isoforms/genetics , RNA, Messenger/biosynthesis , Ryanodine Receptor Calcium Release Channel/genetics , Vasoconstriction
7.
Histochem J ; 33(4): 213-9, 2001 Apr.
Article in English | MEDLINE | ID: mdl-11550802

ABSTRACT

The expression of nitric oxide synthase (NOS) isoforms I, III and protein kinase-Ctheta (PKCtheta) in rat vastus lateralis muscle was demonstrated immunohistochemically and then correlated to the physiological metabolic fibre types: SO (slow-oxidative), FOGI, FOGII (fast-oxidative glycolytic; I more glycolytic, II more oxidative), and FG (fast-glycolytic). NOS expression in muscles from different experimental groups (normal and diabetic rats, with and without Ginkgo biloba extract treatment) was assayed by Western blotting. Generally, NOS I and PKCtheta were co-expressed in fibres with predominantly oxidative metabolism (SO, FOGII). This suggests an interplay of PKCtheta and NOS I in nitric oxide production by oxidative fibres. NOS III was more highly expressed in fibres with predominantly glycolytic metabolism (FOGI, FG). A somewhat lower NOS I immunoreactivity was also found in NOS III positive fibres suggesting that NOS III and NOS I are co-expressed in these fibres. Western blotting revealed that NOS I as well as NOS III expression in the vastus lateralis muscle was down-regulated in diabetes and increased after Ginkgo biloba extract treatment. These effects may be associated with a diminished glucose uptake by myocytes of diabetic musclesand with an improved muscle function after Ginkgo biloba treatment.


Subject(s)
Diabetes Mellitus, Experimental/enzymology , Ginkgo biloba , Isoenzymes/metabolism , Muscle, Skeletal/enzymology , Nitric Oxide Synthase/metabolism , Phytotherapy , Plant Extracts/pharmacology , Protein Kinase C/metabolism , Animals , Blotting, Western , Diabetes Mellitus, Experimental/drug therapy , Image Processing, Computer-Assisted , Immunohistochemistry , Male , Muscle Fibers, Fast-Twitch/drug effects , Muscle Fibers, Fast-Twitch/enzymology , Muscle Fibers, Skeletal/drug effects , Muscle Fibers, Skeletal/enzymology , Muscle Fibers, Slow-Twitch/drug effects , Muscle Fibers, Slow-Twitch/enzymology , Muscle, Skeletal/cytology , Muscle, Skeletal/drug effects , Nitric Oxide Synthase Type I , Nitric Oxide Synthase Type III , Oxidation-Reduction , Plant Extracts/therapeutic use , Protein Kinase C-theta , Rats , Rats, Wistar
8.
Brain Res ; 910(1-2): 106-15, 2001 Aug 10.
Article in English | MEDLINE | ID: mdl-11489260

ABSTRACT

Stroke-prone spontaneously hypertensive rats (SHRSP) are a well-characterized, genetic model for stroke. We showed earlier that the structure and function of the tight junctions in SHRSP blood-brain barrier endothelial cells is disturbed prior to stroke. To investigate the molecular events leading to endothelial dysfunction in SHRSP cerebral capillaries, we carried out suppression subtractive hybridization (SSH) in combination with a cDNA filter screening step. We identified two cDNA fragments that were upregulated in SHRSP, compared to stroke-resistant spontaneously hypertensive rats (SHR), and found open reading frames of 133 and 138 amino acids, respectively. These peptides did not match any known proteins in public databases. A third upregulated SHRSP cDNA fragment was identified as the rat sulfonylurea receptor 2B (SUR2B). We also isolated and cloned the cDNA of the rat homologue for the mouse G-protein signaling 5 (RGS5) regulator. This regulator was downregulated in SHRSP. We used in situ hybridization to show that rat RGS5 is expressed in the brain capillary endothelium and in the choroid plexus. Our findings may lead to the identification of new stroke-related genes.


Subject(s)
ATP-Binding Cassette Transporters , Cerebral Arteries/metabolism , DNA, Complementary/genetics , Endothelium, Vascular/metabolism , Gene Expression Regulation, Developmental/physiology , Hypertension/metabolism , Potassium Channels, Inwardly Rectifying , Rats, Inbred SHR/metabolism , Stroke/metabolism , Amino Acid Sequence , Animals , Base Sequence , Blood-Brain Barrier/genetics , Causality , Cerebral Arteries/pathology , Cerebral Arteries/physiopathology , DNA, Complementary/isolation & purification , DNA, Complementary/metabolism , Endothelium, Vascular/pathology , Endothelium, Vascular/physiopathology , GTP-Binding Proteins/metabolism , Hypertension/complications , Hypertension/genetics , In Situ Hybridization/methods , Molecular Sequence Data , Peptide Fragments/genetics , Potassium Channels/genetics , Potassium Channels/metabolism , RGS Proteins/genetics , RGS Proteins/metabolism , RNA, Messenger/metabolism , Rats , Rats, Inbred SHR/abnormalities , Rats, Inbred SHR/genetics , Receptors, Drug/genetics , Receptors, Drug/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Sequence Homology, Nucleic Acid , Signal Transduction/physiology , Stroke/genetics , Stroke/physiopathology , Sulfonylurea Receptors
9.
Clin Chem Lab Med ; 39(4): 341-5, 2001 Apr.
Article in English | MEDLINE | ID: mdl-11388659

ABSTRACT

Endothelin-1 is the most potent vasoconstrictor known to date. This peptide is believed to play a pathophysiological role in the development of vasospasm, the most important complication of subarachnoid hemorrhage (SAH). In the present study we investigated the release of endothelin-1 in SAH and analyzed the cellular source of this peptide. At a protein and mRNA level we were able to show that endothelin-1 is produced by mononuclear leukocytes. Complementary in vitro studies revealed that aging and subsequent hemolysis of blood is sufficient to induce production of endothelin-1 by mononuclear leukocytes. Thus, cerebrospinal fluid-derived mononuclear leukocytes are a source of endothelin-1 in patients suffering from SAH. This finding may have important therapeutic implications as anti-leukocyte strategies could prevent cerebrovascular complications in SAH patients.


Subject(s)
Endothelin-1/blood , Endothelin-1/metabolism , Subarachnoid Hemorrhage/metabolism , Adult , Aged , Aneurysm/blood , Aneurysm/cerebrospinal fluid , Aneurysm/diagnosis , Blood Flow Velocity , Brain Ischemia/blood , Brain Ischemia/cerebrospinal fluid , Brain Ischemia/diagnosis , Female , Humans , Leukocytes, Mononuclear/metabolism , Male , Middle Aged , RNA, Messenger/metabolism , Reverse Transcriptase Polymerase Chain Reaction
10.
Phys Rev E Stat Nonlin Soft Matter Phys ; 63(6 Pt 1): 061901, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11415139

ABSTRACT

Scroll waves of electrical excitation in heart tissue are implicated in the development of lethal cardiac arrhythmias. Here we study the relation between the geometry of myocardial fibers and the equilibrium shape of a scroll wave filament. Our theory accommodates a wide class of myocardial models with spatially varying diffusivity tensor, adjusted to fit fiber geometry. We analytically predict the exact equilibrium shapes of the filaments. The major conclusion is that the filament shape is a compromise between a straight line and full alignment with the fibers. The degree of alignment increases with the anisotropy ratio. The results, being purely geometrical, are independent of details of ionic membrane mechanisms. Our theoretical predictions have been verified to excellent accuracy by numerically simulating the stable equilibration of a scroll filament in a model of the FitzHugh-Nagumo type.


Subject(s)
Biophysics/methods , Heart/physiology , Muscle Fibers, Skeletal/physiology , Myocardium/metabolism , Animals , Cell Membrane/metabolism , Humans , Ions , Membrane Potentials , Models, Statistical , Models, Theoretical
11.
Phys Rev Lett ; 84(12): 2738-41, 2000 Mar 20.
Article in English | MEDLINE | ID: mdl-11017313

ABSTRACT

Scroll waves in an excitable medium rotate about tubelike filaments, whose ends, when they exist, can lie on the external boundary of the medium or be pinned to an inclusion. We derive a topological rule that governs such pinning. It implies that some configurations cannot occur although they might otherwise have been expected. Heart tissue provides an application of these concepts. Computational illustrations based on a FitzHugh-Nagumo model are given.


Subject(s)
Models, Theoretical , Physics , Kinetics , Models, Cardiovascular , Physical Phenomena
12.
Article in English | MEDLINE | ID: mdl-11046470

ABSTRACT

Excitable media with twisted anisotropy have recently been attracting significant interest because of their applicability to wave propagation in heart tissue. Here we consider the dynamics of an intramural scroll wave whose filament lies initially within an arbitrary layer of mutually parallel cardiac fibers, and drifts parallel to itself from layer to layer. Earlier simulations have demonstrated that such a filament stabilizes in a layer whose fiber direction is the same as its own. In the present paper we analytically derive the trajectory of the filament, and obtain good agreement with earlier numerical data. For sufficiently sparse scrolls, our analysis predicts an equilibrium alignment perpendicular rather than parallel to the fibers.


Subject(s)
Computer Simulation , Muscle Fibers, Skeletal/chemistry , Myocardium/chemistry , Anisotropy , Muscle Fibers, Skeletal/physiology
13.
Stroke ; 31(12): 2971-5, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11108758

ABSTRACT

BACKGROUND AND PURPOSE: The most potent vasoconstrictor known, endothelin-1, is currently considered to mediate cerebral vasospasm in subarachnoid hemorrhage (SAH), which can cause delayed cerebral ischemia. In our study, we performed clinical and in vitro experiments to investigate the origin and the mechanisms of the secretion of endothelin-1 in SAH. METHODS: Endothelin-1 and markers of inflammatory host response (interleukin [IL]-1ss, IL-6, and tumor necrosis factor-alpha) were comparatively quantified in the cerebrospinal fluid (CSF) of SAH patients and control subjects, and concentrations were related to clinical characteristics. Furthermore, mononuclear leukocytes isolated from the CSF of SAH patients and control subjects were analyzed regarding their mRNA expression of endothelin-1 and inflammatory cytokines. Finally, complementary in vitro experiments were performed to investigate whether coincubation of blood and CSF can trigger leukocytic mRNA expression and release of these factors. RESULTS: Activated mononuclear leukocytes in the CSF of SAH patients synthesize and release endothelin-1 in parallel with known acute-phase reactants (IL-1ss, IL-6, and tumor necrosis factor-alpha). Complementary in vitro experiments not only further confirmed this leukocytic origin of endothelin-1 but also showed that aging and subsequent hemolysis of blood is sufficient to induce such endothelin-1 production. CONCLUSIONS: The demonstration that endothelin-1 is produced by activated CSF mononuclear leukocytes suggests that subarachnoid inflammation may represent a therapeutic target to prevent vasospasm and delayed cerebral ischemia after SAH.


Subject(s)
Acute-Phase Proteins/biosynthesis , Cerebrospinal Fluid/cytology , Endothelin-1/blood , Leukocytes/metabolism , Subarachnoid Hemorrhage/blood , Acute-Phase Proteins/analysis , Adult , Aged , Cytokines/blood , Cytokines/cerebrospinal fluid , Endothelin-1/biosynthesis , Female , Humans , Leukocytes/chemistry , Male , Middle Aged , Reverse Transcriptase Polymerase Chain Reaction , Tumor Necrosis Factor-alpha/analysis , Tumor Necrosis Factor-alpha/cerebrospinal fluid
14.
Crit Care Med ; 28(12): 3869-75, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11153628

ABSTRACT

OBJECTIVE: The study was designed to investigate the effects of acetylcholine (ACh) on pulmonary circulation with special regard to mediators that could be involved in the mediation of ACh-induced effects. ACh has been reported to induce either vasodilation or vasoconstriction in the pulmonary circulation of different species. DESIGN: Prospective experimental study in rabbits. SETTING: Experimental laboratory in a university teaching hospital. SUBJECTS: Sixty-six adult rabbits of either sex. INTERVENTIONS: The experiments were performed on 66 isolated and ventilated rabbit lungs that were perfused with a cell- and plasma-free buffer solution. ACh was injected in various concentrations after pulmonary artery preconstriction and in untreated lungs. MEASUREMENTS AND MAIN RESULTS: Pulmonary arterial pressure (PAP) and lung weight gain were monitored continuously. Perfusate samples were taken intermittently to determine endothelin-1 (ET-1), thromboxane A2 (TXA2), and prostacyclin (PGI2) concentrations. ACh in final dosages from 10(-5) to 10(-2) M (n = 6 each) was injected into the pulmonary artery of lungs treated with U46619 to induce pulmonary arterial hypertension or was injected into untreated lungs. To analyze the potential mechanisms of action, ACh (10(-5) M) was administered in additional experiments after pretreatment with either ETA receptor antagonist BQ123 (10(-6) M; n = 6) or the cyclooxygenase inhibitor diclofenac (10 microg/mL; n = 6). In preconstricted pulmonary vessels, ACh (10(-3) and 10(-2) M) initially induced a PAP rise for 10 mins followed by a sustained decrease. In untreated lungs, ACh induced an immediate dose-dependent increase in PAP, requiring as long as 30 mins to return to predrug levels. Simultaneously, significantly elevated TXA2 and PGI2 levels were observed. Furthermore, ET-1 was detected in the perfusate, which was free from ET-1 before ACh administration. Pretreatment with BQ123 reduced substantially the ACh (10(-5) M)-induced PAP increase and the release of TXA2 and PGI2. At 5 mins, the PAP maximum was reduced from 18.5 +/- 3.2 mm Hg to 9.9 +/- 0.65 mm Hg by BQ123 pretreatment (p < .01). An inhibition of PAP increase was also observed after diclofenac pretreatment (11.6 +/- 0.4 mm Hg at 5 mins; p < .05). Inhibitory effects at 5 mins were significantly more pronounced in the BQ123 group compared with the diclofenac group. CONCLUSIONS: The effects of ACh on the pulmonary circulation of isolated rabbit lungs depend on ACh concentration and the basal tone of the arterial vasculature. In lungs with a normal pulmonary vascular resistance, ACh administration causes vasoconstriction via the release of ET-1 and TXA2, whereas vasodilation is induced in preconstricted pulmonary vessels.


Subject(s)
Acetylcholine/physiology , Acetylcholine/therapeutic use , Endothelin-1/physiology , Endothelin-1/therapeutic use , Hypertension, Pulmonary/drug therapy , Hypertension, Pulmonary/physiopathology , Pulmonary Circulation/drug effects , Pulmonary Circulation/physiology , Pulmonary Wedge Pressure/drug effects , Pulmonary Wedge Pressure/physiology , Vasoconstriction/drug effects , Vasoconstriction/physiology , Vasodilation/drug effects , Vasodilation/physiology , 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid , Animals , Cyclooxygenase Inhibitors/pharmacology , Diclofenac/pharmacology , Disease Models, Animal , Dose-Response Relationship, Drug , Drug Evaluation, Preclinical , Drug Interactions , Endothelin Receptor Antagonists , Female , Hypertension, Pulmonary/chemically induced , In Vitro Techniques , Male , Peptides, Cyclic , Rabbits , Thromboxane A2/physiology , Vascular Resistance/drug effects , Vascular Resistance/physiology , Vasoconstrictor Agents
15.
J Appl Physiol (1985) ; 87(6): 2284-9, 1999 Dec.
Article in English | MEDLINE | ID: mdl-10601179

ABSTRACT

Endothelin-1 (ET-1) has been reported to induce pulmonary vasoconstriction via either ET(A) or ET(B) receptors, and vasorelaxation after ET-1 injection has been observed. Our study investigated the effects of ET-1 in isolated rabbit lungs, which were studied at basal tone (part I) and after preconstriction (U-46619; part II). Pulmonary arterial pressure (PAP) and lung weight gain were monitored continuously. In part I, ET-1 (10(-8) M; n = 6; control) was injected after pretreatment with the ET(A)-receptor antagonist BQ-123 (10(-6) M; n = 6) or the ET(B)-receptor antagonist BQ-788 (10(-6) M; n = 6). The same protocol was carried out in part II after elevation of pulmonary vascular tone. ET-1 induced an immediate PAP increase (DeltaPAP 4.3 +/- 0.4 mmHg at 10 min) that was attenuated by pretreatment with BQ-123 (P < 0.05 at 10 min and P < 0.01 thereafter) and that was more pronounced after BQ-788 (P < 0.01 at 10 min and P < 0.001 thereafter). In part II, ET-1 induced an immediate rise in PAP with a maximum after 5 min (DeltaPAP 6.3 +/- 1.4 mmHg), leveling off at DeltaPAP 3.2 +/- 0.2 mmHg after 15 min. Pretreatment with BQ-123 failed to attenuate the increase. BQ-788 significantly reduced the peak pressure at 5 min (0.75 +/- 0.4 mmHg; P < 0.001) as well as the plateau pressure thereafter (P < 0.01). We conclude that ET-1 administration causes pulmonary vasoconstriction independent of basal vascular tone, and, at normal vascular tone, the vasoconstriction seems to be mediated via ET(A) receptors. BQ-788 treatment resulted in even more pronounced vasoconstriction. After pulmonary preconstriction, ET(A) antagonism exerted no effects on PAP, whereas ET(B) antagonism blocked the PAP increase. Therefore, ET-1-induced pulmonary vasoconstriction is shifted from an ET(A)-related to an ET(B)-mediated mechanism after pulmonary vascular preconstriction.


Subject(s)
Endothelin-1/pharmacology , Pulmonary Circulation/drug effects , Receptors, Endothelin/physiology , Vasoconstriction/drug effects , Animals , Antihypertensive Agents/pharmacology , Blood Pressure/drug effects , Blood Vessels/drug effects , Female , Male , Oligopeptides/pharmacology , Peptides, Cyclic/pharmacology , Piperidines/pharmacology , Pulmonary Artery/drug effects , Pulmonary Artery/physiology , Rabbits , Receptor, Endothelin A , Receptor, Endothelin B , Vasomotor System/drug effects
16.
Arterioscler Thromb Vasc Biol ; 19(1): 178-85, 1999 Jan.
Article in English | MEDLINE | ID: mdl-9888881

ABSTRACT

The heparin-binding protein vascular endothelial growth factor (VEGF) is a highly specific growth factor for endothelial cells. VEGF binds to specific tyrosine kinase receptors, which mediate intracellular signaling. We investigated 2 hypotheses: (1) VEGF affects intracellular calcium [Ca2+]i regulation and [Ca2+]i-dependent messenger systems; and (2) these mechanisms are important for VEGF's proliferative effects. [Ca2+]i was measured in human umbilical vein endothelial cells using fura-2 and fluo-3. Protein kinase C (PKC) activity was measured by histone-like pseudosubstrate phosphorylation. PKC isoform distribution was observed with confocal microscopy and Western blot. Inhibition of PKC isoforms was assessed by specific antisense oligonucleotides (ODN) for the PKC isoforms. VEGF (10 ng/mL) induced a transient increase in [Ca2+]i followed by a sustained elevation. The sustained [Ca2+]i plateau was abolished by EGTA. Pertussis toxin also abolished the plateau phase, whereas the initial peak was not affected. The PKC isoforms alpha, delta, epsilon, and zeta were identified in endothelial cells. VEGF induced a translocation of PKC-alpha and PKC-zeta toward the nucleus and the perinuclear area, whereas cellular distribution of PKC-delta and PKC-epsilon was not influenced. Cell exposure to TPA led to a down-regulation of PKC-alpha and reduced the proliferative effect of VEGF. VEGF-induced endothelial cell proliferation also was reduced by the PKC inhibitors staurosporine and calphostin C. Specific down-regulation of PKC-alpha and PKC-zeta with antisense ODN reduced the proliferative effect of VEGF significantly. Our data show that VEGF induces initial and sustained Ca2+ influx. VEGF leads to the translocation of the [Ca2+]i-sensitive PKC isoform alpha and the atypical PKC isoform zeta. Antisense ODN for these PKC isoforms block VEGF-induced proliferation. These findings suggest that PKC isoforms alpha and zeta are important for VEGF's angiogenic effects.


Subject(s)
Cell Division , Endothelial Growth Factors/pharmacology , Endothelium, Vascular/cytology , Isoenzymes/metabolism , Lymphokines/pharmacology , Protein Kinase C/metabolism , Calcium/metabolism , Calcium/pharmacology , Egtazic Acid/pharmacology , Endothelium, Vascular/drug effects , Endothelium, Vascular/metabolism , Enzyme Inhibitors/pharmacology , Humans , Isoenzymes/antagonists & inhibitors , Microscopy, Confocal , Naphthalenes/pharmacology , Oligodeoxyribonucleotides, Antisense/pharmacology , Pertussis Toxin , Protein Kinase C/antagonists & inhibitors , Protein Kinase C-alpha , Signal Transduction , Staurosporine/pharmacology , Umbilical Veins , Vascular Endothelial Growth Factor A , Vascular Endothelial Growth Factors , Virulence Factors, Bordetella/pharmacology
17.
Article in English | MEDLINE | ID: mdl-11969477

ABSTRACT

We consider the drift of a stable, nonmeandering rotating spiral wave in a singly diffusive FitzHugh-Nagumo medium with generic reaction functions; the drift is assumed to be caused by a weak time-independent diffusivity gradient or convection term in the fast-variable equation. We address, to first order in the perturbation, the standard problem whose statement reads, "Given the unperturbed solution, as well as the model's parameters, predict the speed and direction of the drift in terms of the strength and direction of the perturbation." Our main results are as follows: First, we establish a mathematical equivalence between true gradients and convective perturbations; second, a variety of numerical examples, taken from computer simulations, are presented as a reference base for testing drift theories; and third, we propose a semiempirical solution to the drift problem, requiring only two quantities to be measured off the unperturbed spiral, namely, its period of rotation and the value of the fast variable at its center; good agreement with numerical simulations is found for moderately sparse spirals.


Subject(s)
Biophysics , Biophysical Phenomena , Models, Statistical , Models, Theoretical
18.
Kidney Int ; 53(6): 1550-8, 1998 Jun.
Article in English | MEDLINE | ID: mdl-9607185

ABSTRACT

Antisense oligodesoxynucleotides (ODN) provide a novel strategy to inhibit RNA transcription and thereby the synthesis of the gene product. Because antisense ODN hybridize with the mRNA strand, they are highly specific. Their backbone structure has been modified to phosphorothioates or phosphoamidates so that they can better withstand degradation after delivery. We have shown that antisense ODN are a useful research tool to elucidate intracellular processes. The example we provide involves the inhibition of PKC signaling. Furthermore, we have shown the potential clinical utility of antisense treatment. We successfully inhibited the expression of the surface adhesion molecule ICAM-1 with antisense ODN in a model of reperfusion injury. This model is highly applicable to the problem of delayed graft function in humans. However, "getting there" is a major problem and clearly less than half the fun. Cationic substances such as lipofectin have worked sufficiently well in the experimental setting. Viral gene transfer offers a possibility; however, viruses produce an additional series of problems. Liposomes may not provide sufficient transfer efficiency. Coating liposomes with viral fusion proteins may offer an ideal way with which to deliver the goods into the cytoplasm of the target cell.


Subject(s)
Cardiovascular Diseases/physiopathology , Kidney Diseases/physiopathology , Oligonucleotides, Antisense , Animals , Cardiovascular Diseases/therapy , Gene Targeting , Gene Transfer Techniques , Genetic Therapy , Humans , Intercellular Adhesion Molecule-1/genetics , Isoenzymes/genetics , Kidney Diseases/therapy , Oligonucleotides, Antisense/genetics , Oligonucleotides, Antisense/pharmacology , Oligonucleotides, Antisense/therapeutic use , Protein Kinase C/genetics , Protein Kinase C-alpha
19.
J Mol Cell Cardiol ; 29(6): 1525-39, 1997 Jun.
Article in English | MEDLINE | ID: mdl-9220339

ABSTRACT

Pluripotent embryonic stem (ES) cells spontaneously differentiate via embryo-like aggregates into cardiomyocytes of pacemaker-, atrium- and ventricle-like type, which can be distinguished by their specific patterns of action potentials. It has been shown that retinoic acid (RA) treatment during ES cell differentiation increases the number of cardiomyocytes in a time- and concentration-dependent manner. In order to test the effect of RA on cardiomyocyte differentiation and specialization into ventricle-like cardiomyocytes, we studied gene expression of beta-galactosidase driven by the ventricular myosin light chain-2 (MLC-2v) promoter as an indicator for ventricular differentiation. Clones containing the stably integrated expression vector pGNA/MLC-2.1 were selected, which revealed an increase of beta-galactosidase activity in cardiomyocytes of embryoid bodies at day 7 + 16. RA, both, in the all-trans and in the 9-cis configuration resulted in a significant acceleration of cardiomyocyte differentiation and a transient increase of beta-galactosidase activity. To test whether this acceleration of cardiac differentiation and RA-induced increase of the MLC-2v promotor/beta-galactosidase activity reflects an increase of cardiac- and ventricle-specific gene expression, a semi-quantitative RT-PCR analysis was performed for alpha-cardiac myosin heavy chain (alpha-MHC) and MLC-2v genes. It was shown that both 10(-8) M and 10(-9) M RA resulted in an increased level of alpha-cardiac MHC and MLC-2v mRNA in embryoid bodies in early, but not in terminal developmental stages. This led us to the conclusion that the RA-induced accelerated expression of cardiac-specific genes results in an enhanced development of ventricular cardiomyocytes. An increased number of ventricle-like cells after RA treatment was also found by patch-clamp analysis. The number of cardiomyocytes with Purkinje- and ventricle-like properties was shown to be increased by RA, whereas the number of pacemaker- and atrium-like cells was reduced and early pacemaker cells were not quantitatively affected.


Subject(s)
Heart Ventricles/cytology , Stem Cells/drug effects , Tretinoin/pharmacology , Alitretinoin , Animals , Cell Differentiation/drug effects , Electrophysiology , Gene Expression Regulation, Developmental/drug effects , Genetic Vectors/genetics , Heart Atria/cytology , Heart Atria/drug effects , Heart Ventricles/drug effects , Heart Ventricles/embryology , Mice , Myosin Heavy Chains/genetics , Myosin Light Chains/genetics , Patch-Clamp Techniques , Promoter Regions, Genetic , Purkinje Cells/drug effects , Purkinje Cells/physiology , RNA, Messenger/drug effects , RNA, Messenger/metabolism , Recombinant Proteins/drug effects , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Transfection , beta-Galactosidase/drug effects , beta-Galactosidase/genetics , beta-Galactosidase/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...